Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending

BACKGROUND: In the United States, there is well-documented regional variation in prescription drug spending. However, the specific role of physician adoption of brand name drugs on the variation in patient-level prescription drug spending is still being investigated across a multitude of drug classe...

Descripción completa

Detalles Bibliográficos
Autores principales: Metes, Ilinca D., Xue, Lingshu, Chang, Chung-Chou H., Huskamp, Haiden A., Gellad, Walid F., Lo-Ciganic, Wei-Hsuan, Choudhry, Niteesh K., Richards-Shubik, Seth, Guclu, Hasan, Donohue, Julie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794771/
https://www.ncbi.nlm.nih.gov/pubmed/31619229
http://dx.doi.org/10.1186/s12913-019-4520-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794771/
https://www.ncbi.nlm.nih.gov/pubmed/31619229
http://dx.doi.org/10.1186/s12913-019-4520-4

Ejemplares similares